RemeGen Co Ltd
SSE:688331

Watchlist Manager
RemeGen Co Ltd Logo
RemeGen Co Ltd
SSE:688331
Watchlist
Price: 65.6 CNY 1.11% Market Closed
Market Cap: 35.7B CNY

Wall Street
Price Targets

Price Targets Summary
RemeGen Co Ltd

Wall Street analysts forecast RemeGen Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RemeGen Co Ltd is 46.23 CNY with a low forecast of 28.28 CNY and a high forecast of 60.65 CNY.

Lowest
Price Target
28.28 CNY
57% Downside
Average
Price Target
46.23 CNY
30% Downside
Highest
Price Target
60.65 CNY
8% Downside
RemeGen Co Ltd Competitors:
Price Targets
BONEX
Bonesupport Holding AB
75% Upside
PTCT
PTC Therapeutics Inc
22% Upside
300601
Shenzhen Kangtai Biological Products Co Ltd
19% Upside
AGIO
Agios Pharmaceuticals Inc
55% Upside
4BB
4Basebio PLC
76% Upside
MNKD
MannKind Corp
177% Upside
BIIB
Biogen Inc
32% Upside
PEB
Pacific Edge Ltd
21% Downside

Revenue
Forecast

Revenue Estimate
RemeGen Co Ltd

The compound annual growth rate of RemeGen Co Ltd's revenue for the next 3 years is 37%.

N/A
Past Growth
37%
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Operating Income
Forecast

Operating Income Estimate
RemeGen Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
11%
Average Beat

Net Income
Forecast

Net Income Estimate
RemeGen Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
17%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RemeGen Co Ltd's stock price target?
Price Target
46.23 CNY

According to Wall Street analysts, the average 1-year price target for RemeGen Co Ltd is 46.23 CNY with a low forecast of 28.28 CNY and a high forecast of 60.65 CNY.

What is RemeGen Co Ltd's Revenue forecast?
Projected CAGR
37%

The compound annual growth rate of RemeGen Co Ltd's revenue for the next 3 years is 37%.

Back to Top